{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:10:23Z","timestamp":1784596223062,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhejiang Natural Science Foundation \/ Public Welfare Technology Research Plan \/ Social Development","award":["LGF19H040006"],"award-info":[{"award-number":["LGF19H040006"]}]},{"name":"Hangzhou Science and Technology Plan Guide Project \/ Agriculture and Social Development","award":["20181228Y13"],"award-info":[{"award-number":["20181228Y13"]}]},{"name":"Hangzhou Health Science and Technology Plan Project","award":["2017A55"],"award-info":[{"award-number":["2017A55"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>To determine whether advanced maternal age (AMA) causes changes in the maternal serum markers of Trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester of pregnancy. Our research aims to develop new cut-off values for AMA in order to reduce the need for further invasive testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective cohort study involved 12,739 pregnant women with AMA and 197,101 pregnant women with non-AMA. We then compared the two groups with respect to the positive rate and positive predictive value (PPV) of Trisomy 21, 18 and ONTD. Pregnant women with Trisomy 21, 18 and ONTD were diagnosed by karyotyping the amniotic fluid and by ultrasound diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared to the non-AMA group, the multiple of the median (MOM) of free beta- human chorionic gonadotropin (free \u03b2-hCG), alpha-fetoprotein (AFP), and the risk value forTrisomy 21, were significantly higher in the AMA group (all<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The positive rates of Trisomy 21, 18, and ONTD in the AMA group were significantly higher than those in the control group (all<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). In the AMA group, the PPVs for Trisomy 21 and other deformities were significantly higher (all<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), although the PPVs for Trisomy 18 and ONTD were similar to those of the non-AMA group. The area under the curve (AUC) values for the AMA group were higher than the non-AMA group, based on free \u03b2-hCG MoM, AFP MoM, and the risk value of Trisomy 21. The cut-off value for the risk value of Trisomy 21 was 1\/172 for the AMA, group and 1\/780 for the non-AMA group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The positive rates for Trisomy 21, 18 and ONTD, and the PPV for Trisomy 21 and other deformities were significantly higher in the AMA group. It is essential for pregnant women with AMA to be tested using appropriate cut-off values of serum markers screening for Trisomy 21 during the second trimester of pregnancy to improve the efficacy of prenatal screening and reduce the need for further invasive testing.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12884-020-03464-z","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T12:05:22Z","timestamp":1607947522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1532-6049","authenticated-orcid":false,"given":"Yiming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"issue":"1","key":"3464_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tcb.2016.09.002","volume":"27","author":"A Webster","year":"2017","unstructured":"Webster A, Schuh M. Mechanisms of aneuploidy in human eggs. Trends Cell Biol. 2017;27(1):55\u201368.","journal-title":"Trends Cell Biol"},{"key":"3464_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1750-1172-7-81","volume":"7","author":"A Cereda","year":"2012","unstructured":"Cereda A, Carey JC. The trisomy 18 syndrome. Orphanet J Rare Dis. 2012;7:81.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"3464_CR3","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.cell.2017.02.002","volume":"168","author":"S Wang","year":"2017","unstructured":"Wang S, Hassold T, Hunt P, White MA, Zickler D, Kleckner N, Zhang L. Inefficient crossover maturation underlies elevated aneuploidy inHuman female meiosis. Cell. 2017;168(6):977\u201389.","journal-title":"Cell"},{"issue":"Suppl 1","key":"3464_CR4","first-page":"S5","volume":"35","author":"MA Salih","year":"2014","unstructured":"Salih MA, Murshid WR, Seidahmed MZ. Classification, clinical features, and genetics of neural tube defects. Saudi Med J. 2014;35(Suppl 1):S5\u2013S14.","journal-title":"Saudi Med J"},{"issue":"Suppl1","key":"3464_CR5","first-page":"S29","volume":"35","author":"MZ Seidahmed","year":"2014","unstructured":"Seidahmed MZ, Abdelbasit OB, Shaheed MM, Alhussein KA, Miqdad AM, Khalil MI, Al-Enazy NM, Salih MA. Epidemiology of neural tube defects. Saudi Med J. 2014;35(Suppl1):S29\u201335.","journal-title":"Saudi Med J"},{"issue":"1","key":"3464_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/jog.12144","volume":"40","author":"Z Ocak","year":"2014","unstructured":"Ocak Z, Ozlu T, Yazicioglu HF, Ozyurt O, Aygun M. Clinical and cytogenetic results of a large series of amniocentesis cases from Turkey: report of 6124 cases. J Obstet Gynaecol Res. 2014;40(1):139\u201346.","journal-title":"J Obstet Gynaecol Res"},{"issue":"3","key":"3464_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ajog.2016.04.029","volume":"215","author":"MI Evans","year":"2016","unstructured":"Evans MI, Wapner RJ, Berkowitz RL. Noninvasive prenatal screening or advanced diagnostic testing: caveat emptor. Am J Obstet Gynecol. 2016;215(3):298\u2013305.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"3464_CR8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41436-019-0681-0","volume":"22","author":"GE Palomaki","year":"2020","unstructured":"Palomaki GE, Bupp C, Gregg AR, Norton ME, Oglesbee D, Best RG. Laboratory screening and diagnosis of open neural tube defects, 2019 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2020;22(3):462\u201374.","journal-title":"Genet Med"},{"key":"3464_CR9","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.11389","volume":"4","author":"AP Zielinska","year":"2015","unstructured":"Zielinska AP, Holubcova Z, Blayney M, Elder K, Schuh M. Sister kinetochore splitting and precocious disintegration of bivalents could explain the maternal age effect. Elife. 2015;4:e11389.","journal-title":"Elife"},{"key":"3464_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13584-015-0019-6","volume":"4","author":"J Grinshpun-Cohen","year":"2015","unstructured":"Grinshpun-Cohen J, Miron-Shatz T, Berkenstet M, Pras E. The limited effect of information on Israeli pregnant women at advanced maternal age who decide to undergo amniocentesis. Isr J Health Policy Res. 2015;4:23.","journal-title":"Isr J Health Policy Res"},{"issue":"3","key":"3464_CR11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1055\/s-0029-1245560","volume":"32","author":"A Hagen","year":"2011","unstructured":"Hagen A, Entezami M, Gasiorek-Wiens A, Albig M, Becker R, Knoll U, Stumm M, Wegner RD. The impact of first trimester screening and early fetal anomaly scan on invasive testing rates in women with advanced maternal age. Ultraschall Med. 2011;32(3):302\u20136.","journal-title":"Ultraschall Med"},{"issue":"14","key":"3464_CR12","first-page":"2113","volume":"36","author":"Q Sun","year":"2015","unstructured":"Sun Q, Xu Z, Bai X, Li D. Analysis of screening and prenatal diagnosis of Down syndrome in the second trimester of pregnancy in Guangzhou. Int J Lab Med. 2015;36(14):2113\u20134 [Artile in Chinese].","journal-title":"Int J Lab Med"},{"issue":"3","key":"3464_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/pd.2434","volume":"30","author":"N Nakata","year":"2010","unstructured":"Nakata N, Wang Y, Bhatt S. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age. Prenat Diagn. 2010;30(3):198\u2013206.","journal-title":"Prenat Diagn"},{"issue":"6","key":"3464_CR14","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1097\/01.AOG.0000127008.14792.14","volume":"103","author":"PA Benn","year":"2004","unstructured":"Benn PA, Egan JF, Fang M, Smith-Bindman R. Changes in the utilization of prenatal diagnosis. Obstet Gynecol. 2004;103(6):1255\u201360.","journal-title":"Obstet Gynecol."},{"issue":"4","key":"3464_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/ajcp\/97.4.541","volume":"97","author":"JL Bock","year":"1992","unstructured":"Bock JL. Current issues in maternal serum alpha-fetoprotein screening. Am J Clin Pathol. 1992;97(4):541\u201354.","journal-title":"Am J Clin Pathol."},{"key":"3464_CR16","unstructured":"The Professional Committee of Medical Service Standards of the Ministry of Health. Technical Standards for Prenatal Screening and Diagnosis of Common Fetal Chromosome Abnormalities and Open Neural Tube Defects, 2010-10-01. Article in Chinese."},{"issue":"1","key":"3464_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/ajmg.a.30553","volume":"133A","author":"RG Resta","year":"2005","unstructured":"Resta RG. Changing demographics of advanced maternal age (AMA) and the impact on the predicted incidence of Down syndrome in the United States: implications for prenatal screening and genetic counseling. Am J Med Genet A. 2005;133A(1):31\u20136.","journal-title":"Am J Med Genet A."},{"issue":"10","key":"3464_CR18","first-page":"737","volume":"43","author":"QW Qi","year":"2008","unstructured":"Qi QW, Jiang YL, Liu JT, Bian XM, Li Y, Lu SM, Zhu BS, Wang H, Xu ZF, Pan XY, et al. Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study. Zhonghua Fu Chan Ke Za Zhi. 2008;43(10):737\u201341.","journal-title":"Zhonghua Fu Chan Ke Za Zhi."},{"issue":"1","key":"3464_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/humupd\/dmn047","volume":"15","author":"CF Wright","year":"2009","unstructured":"Wright CF, Burton H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update. 2009;15(1):139\u201351.","journal-title":"Hum Reprod Update."},{"key":"3464_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejogrb.2016.08.038","volume":"206","author":"A Kurtovic-Kozaric","year":"2016","unstructured":"Kurtovic-Kozaric A, Mehinovic L, Malesevic R, Mesanovic S, Jaros T, Stomornjak-Vukadin M, Mackic-Djurovic M, Ibrulj S, Kurtovic-Basic I, Kozaric M. Ten-year trends in prevalence of Down syndrome in a developing country: impact of the maternal age and prenatal screening. Eur J Obstet Gynecol Reprod Biol. 2016;206:79\u201383.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"3464_CR21","doi-asserted-by":"crossref","unstructured":"Practice Bulletin No ACOG 77. Screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007;109(1):217\u201327.","DOI":"10.1097\/00006250-200701000-00054"},{"issue":"4","key":"3464_CR22","first-page":"199","volume":"18","author":"D Chelli","year":"2008","unstructured":"Chelli D, Dimassi K, Chaabouni M, Ben SM, Mssaed H, Bchir F, Zouaoui B, Sfar E, Gaigi S, Chelli H, et al. Prenatal diagnosis of trisomy 21: the Tunisian experience. Sante. 2008;18(4):199\u2013203.","journal-title":"Sante."},{"issue":"5","key":"3464_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1471-0528.1987.tb03115.x","volume":"94","author":"HS Cuckle","year":"1987","unstructured":"Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol. 1987;94(5):387\u2013402.","journal-title":"Br J Obstet Gynaecol."},{"issue":"4","key":"3464_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000080578","volume":"58","author":"WJ Gyselaers","year":"2004","unstructured":"Gyselaers WJ, Vereecken AJ, van Herck E, Straetmans DP, de Jonge ET, Ombelet WU, Nijhuis JG. Single-step maternal serum screening for trisomy 21 in the era of combined or integrated screening. Gynecol Obstet Investig. 2004;58(4):221\u20134.","journal-title":"Gynecol Obstet Investig."},{"issue":"11","key":"3464_CR25","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.3760\/cma.j.issn.0366-6999.20122345","volume":"126","author":"QW Qi","year":"2013","unstructured":"Qi QW, Jiang YL, Zhou XY, Liu JT, Yin J, Bian XM. Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: a prospective study. Chin Med J. 2013;126(11):2007\u201310.","journal-title":"Chin Med J."},{"issue":"3","key":"3464_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3109\/14767058.2012.733756","volume":"26","author":"N Danisman","year":"2013","unstructured":"Danisman N, Kahyaoglu S, Celen S, Kahyaoglu I, Candemir Z, Yesilyurt A, Cakar ES. A retrospective analysis of amniocenteses performed for advanced maternal age and various other indications in Turkish women. J Matern Fetal Neonatal Med. 2013;26(3):242\u20135.","journal-title":"J Matern Fetal Neonatal Med."}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-020-03464-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T02:31:44Z","timestamp":1724034704000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-020-03464-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3464"],"URL":"https:\/\/doi.org\/10.1186\/s12884-020-03464-z","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"26 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Hangzhou Women\u2019s Hospital (Hangzhou Maternity and Child Health Care Hospital) ethics committee, and the approval number was [2018] medical ethics (004) No.01. The data used in this study was anonymised before its use. Patients\u2019 consents were not required because this was a retrospective study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable; this was a retrospective study and no individual person\u2019s personal information is included.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"776"}}